Scientists have shown for the first time why a feeling of control helps us reduce pain. The research, carried out at the Wellcome Trust Centre for Neuroimaging at UCL, London, has implications for how patients with persistent pain can cope...

1. Making Fly Synapses with and without Glutamate Receptors Andreas Schmid, Gang Qin, Carolin Wichmann, Robert J. Kittel, Sara Mertel, Wernher Fouquet, Manuela Schmidt, Manfred Heckmann, and Stephan J. Sigrist A small army of structural pr...

An international team of scientists, lead by Dr. Frederic Charron at the IRCM, and Drs Ami Okada, Sue McConnell, and Marc Tessier-Lavigne in the USA, have made a discovery which could help treat spinal cord injuries and neurodegenerative d...

The urgent search for a medication to treat prion diseases has led scientists in Germany to synthesize a group of compounds, including one that is 15 times more potent than an approved drug now being tested in clinical trials. Their re...

The funds will support research centers at WPI that are developing systems to improve the odds of surviving battlefield injuries and technology to integrate prosthetic limbs and organs with the nervous system. Two groundbreaking research p...

Glossolalia, otherwise referred to as "speaking in tongues," has been around for thousands of years, and references to it can be found in the Old and New Testament. Speaking in tongues is an unusual mental state associated with specific re...

An experimental drug called gaboxadol may soon help millions of bleary-eyed insomniacs get to sleep, and a multi-center team of U.S. scientists believes they've pinpointed just how the drug works. Neuroscientist researchers from Weill Corn...

Innovative Neurotronics, Inc. (IN, Inc.), a wholly-owned subsidiary of Hanger Orthopedic Group, Inc., announced today that it has received CE Mark approval for the WalkAide(R) System, a neuromuscular medical device that treats a condition...

A test using cultured cells provides an effective way to screen drugs against Huntington's disease and shows that two compounds - memantine and riluzole - are most effective at keeping cells alive under conditions that mimic the disorder,...

The National Institute of Clinical Excellence (NICE), who last week rejected appeals to allow patients with mild Alzheimer's to receive the life-changing medication donepezil (Aricept), will hopefully re-appraise their decision in three-ye...